SARAH LIVENGOOD: Open Payments
NPI 1548751282 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$258 in 9 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $132 · 2025 $258
Food & beverage: $258
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $132 |
| Optinose US, Inc. | 3 | $52 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Paratek Pharmaceuticals, Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
Products named: DUPIXENT, XHANCE, NUCALA.
Industry payments across PA — which companies pay providers there.
